Retatrutide

Creator

Creator

Seonglae Cho

Created

Created

2023 Jun 29 11:24

Editor

Editor

Seonglae Cho

Edited

Edited

2023 Sep 23 15:26

Refs

Refs

https://www.nejm.org/doi/full/10.1056/NEJMoa2301972

Michael Weintraub on Twitter

NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most effective anti-obesity med to date and approaches bariatric surgery outcomes. pic.twitter.com/rAecoE3d0t— Michael Weintraub (@MWeintraubMD) June 26, 2023

https://twitter.com/MWeintraubMD/status/1673435733497978888

Michael Weintraub on Twitter

https://twitter.com/DanielJDrucker/status/1673383917888348174

Recommendations

/////////